Menu
Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 3
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 2, 2008
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
Mathieu C Tamby, Amélie Servettaz, Nicolas Tamas, Joseph Reinbolt, Frédéric Caux, et al
Biologics: Targets and Therapy 2008, 2:583-591
Published Date: 12 September 2008
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy
R Bucciardini, M Massella, A Corpolongo, P Narciso, V Fragola, et al
Biologics: Targets and Therapy 2008, 2:577-581
Published Date: 12 September 2008
The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice
Chung-Man Yeung, Yi Tan, Sidney Tam, Liwei Lu, King-Hung Ko, et al
Biologics: Targets and Therapy 2008, 2:571-576
Published Date: 12 September 2008
Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
Peter J O’Brien, Rajeev Ramanathan, Jonathan M Yingling, Jose Baselga, Mace L Rothenberg, et al
Biologics: Targets and Therapy 2008, 2:563-569
Published Date: 12 September 2008
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Jesús Vázquez, Marta Aghazarian, Eduardo Lasalvia-Galante, et al
Biologics: Targets and Therapy 2008, 2:555-561
Published Date: 12 September 2008
Functional and gene expression analysis of hTERT overexpressed endothelial cells
Haruna Takano, Satoshi Murasawa, Takayuki Asahara
Biologics: Targets and Therapy 2008, 2:547-554
Published Date: 12 September 2008
Novel targets for immunotherapy in glomerulonephritis
Mary H Foster
Biologics: Targets and Therapy 2008, 2:531-545
Published Date: 12 September 2008
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
Bernard Escudier, Jan Cosaert, Sangeeta Jethwa
Biologics: Targets and Therapy 2008, 2:517-530
Published Date: 12 September 2008
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
Shannon Puhalla, Adam Brufsky
Biologics: Targets and Therapy 2008, 2:505-515
Published Date: 12 September 2008
New treatment options in the management of IBD – focus on colony stimulating factors
Josué Barahona-Garrido, Jesús K Yamamoto-Furusho
Biologics: Targets and Therapy 2008, 2:501-504
Published Date: 12 September 2008
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
Judith E Karp, Jeffrey E Lancet
Biologics: Targets and Therapy 2008, 2:491-500
Published Date: 12 September 2008
Lepirudin in the management of patients with heparin-induced thrombocytopenia
Sirak Petros
Biologics: Targets and Therapy 2008, 2:481-490
Published Date: 12 September 2008
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®
Ferdinand Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn
Biologics: Targets and Therapy 2008, 2:463-479
Published Date: 12 September 2008
Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E Blum
Biologics: Targets and Therapy 2008, 2:453-462
Published Date: 12 September 2008
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
Lina Nordquist, Fredrik Palm, Bradley T Andresen
Biologics: Targets and Therapy 2008, 2:441-452
Published Date: 12 September 2008
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Asunción Mejías, Octavio Ramilo
Biologics: Targets and Therapy 2008, 2:433-439
Published Date: 12 September 2008
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
Aldo M Roccaro, Irene M Ghobrial, Simona Blotta, Steven P Treon, Michele Malagola, et al
Biologics: Targets and Therapy 2008, 2:419-431
Published Date: 12 September 2008
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses
Willem MA Verhoeven, Siegfried Tuinier, Ineke van der Burgt
Biologics: Targets and Therapy 2008, 2:409-417
Published Date: 12 September 2008
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside
Ana Villegas, Fernando A Gonzalez, Leopoldo Llorente, Santiago Redondo
Biologics: Targets and Therapy 2008, 2:397-407
Published Date: 12 September 2008
The role of B cells in systemic sclerosis
Marina D Kraaij, Jacob M van Laar
Biologics: Targets and Therapy 2008, 2:389-395
Published Date: 12 September 2008
Infliximab in ulcerative colitis
Avi Levin, Oren Shibolet
Biologics: Targets and Therapy 2008, 2:379-388
Published Date: 12 September 2008
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Satya Prakash, Aleksandra Malgorzata Urbanska
Biologics: Targets and Therapy 2008, 2:355-378
Published Date: 12 September 2008
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Neil Ghodadra, Kern Singh
Biologics: Targets and Therapy 2008, 2:345-354
Published Date: 12 September 2008